Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' reply

Mark D. Russell; Mark Gibson; Benjamin Zuckerman; Kanta Kumar; Shirish Dubey; Maryam A Adas; Edward Alveyn; Samir Patel; Zijing Yang; Katie Bechman; Elizabeth Price; Sarah Gallagher; Andrew P. Cope; Sam Norton; James B. Galloway

doi:10.1016/S2665-9913(25)00029-3

Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' reply

Mark D. Russell, Mark Gibson, Benjamin Zuckerman, Kanta Kumar, Shirish Dubey, Maryam A Adas, Edward Alveyn, Samir Patel, Zijing Yang, Katie Bechman, Elizabeth Price, Sarah Gallagher, Andrew P. Cope, Sam Norton, James B. Galloway

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	e159-e160
Journal	The Lancet Rheumatology
Volume	7
Issue number	3
Early online date	5 Feb 2025
DOIs	https://doi.org/10.1016/S2665-9913(25)00029-3
Publication status	Published - Mar 2025

Access to Document

10.1016/S2665-9913(25)00029-3

Cite this

Russell, M. D., Gibson, M., Zuckerman, B., Kumar, K., Dubey, S., Adas, M. A., Alveyn, E., Patel, S., Yang, Z., Bechman, K., Price, E., Gallagher, S., Cope, A. P., Norton, S., & Galloway, J. B. (2025). Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' reply. The Lancet Rheumatology, 7(3), e159-e160. https://doi.org/10.1016/S2665-9913(25)00029-3

@article{e2578ad6d7774dcb83eadf60a801e416,

title = "Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' reply",

author = "Russell, {Mark D.} and Mark Gibson and Benjamin Zuckerman and Kanta Kumar and Shirish Dubey and Adas, {Maryam A} and Edward Alveyn and Samir Patel and Zijing Yang and Katie Bechman and Elizabeth Price and Sarah Gallagher and Cope, {Andrew P.} and Sam Norton and Galloway, {James B.}",

year = "2025",

month = mar,

doi = "10.1016/S2665-9913(25)00029-3",

language = "English",

volume = "7",

pages = "e159--e160",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Elsevier",

number = "3",

}

Russell, MD , Gibson, M, Zuckerman, B, Kumar, K, Dubey, S, Adas, MA , Alveyn, E , Patel, S , Yang, Z , Bechman, K, Price, E, Gallagher, S, Cope, AP , Norton, S & Galloway, JB 2025, 'Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' reply', The Lancet Rheumatology, vol. 7, no. 3, pp. e159-e160. https://doi.org/10.1016/S2665-9913(25)00029-3

TY - JOUR

T1 - Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' reply

AU - Russell, Mark D.

AU - Gibson, Mark

AU - Zuckerman, Benjamin

AU - Kumar, Kanta

AU - Dubey, Shirish

AU - Adas, Maryam A

AU - Alveyn, Edward

AU - Patel, Samir

AU - Yang, Zijing

AU - Bechman, Katie

AU - Price, Elizabeth

AU - Gallagher, Sarah

AU - Cope, Andrew P.

AU - Norton, Sam

AU - Galloway, James B.

PY - 2025/3

Y1 - 2025/3

UR - http://www.scopus.com/inward/record.url?scp=85218440548&partnerID=8YFLogxK

U2 - 10.1016/S2665-9913(25)00029-3

DO - 10.1016/S2665-9913(25)00029-3

M3 - Article

C2 - 39922215

SN - 2665-9913

VL - 7

SP - e159-e160

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

IS - 3

ER -

Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' reply

Access to Document

Other files and links

Cite this